Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy?
- PMID: 33281107
- PMCID: PMC7687579
- DOI: 10.1016/j.pulmoe.2020.10.011
Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy?
Comment on
-
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.Lancet. 2020 Jun 13;395(10240):e102. doi: 10.1016/S0140-6736(20)31290-3. Epub 2020 Jun 3. Lancet. 2020. PMID: 32504543 Free PMC article. No abstract available.
References
-
- Beato-Víbora P.I. No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes. Diabetes Technol Ther. 2020 doi: 10.1089/dia.2020.0184. Epub ahead of print. Retraction in: Diabetes Technol Ther.22, 2020, 643. doi: 10.1089/dia.2020.0184.retract. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources